Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus

Study Title

A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus

Teva Identifier

TV-4710/201

ClinicalTrials.gov Identifier

NCT00203151

Study Status

Terminated

Trial Condition(s)

Systemic Lupus Erythematosus

Interventions

Drug: edratide

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
inflammation and infections icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 65 Years

Trial Duration

07/01/2005 - 02/01/2007

Phase

Phase 2

Study Type

Interventional